Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Responsiveness and minimum important differences for the erection quality scale.

Raymond C Rosen1, John Wincze, Martin D Mollen

  • 1Department of Psychiatry, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey, USA. rrosen@neriscience.com

The Journal of Urology
|September 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining clinically relevant responses in erectile function: an SMSNA position statement.

The journal of sexual medicine·2026
Same author

Psychometric Evaluation of the Celiac Disease Symptom Diary 2.1<sup>©</sup> Using Data from the Virtual Celiac Symptoms Study.

Patient related outcome measures·2026
Same author

Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension.

The Journal of clinical endocrinology and metabolism·2025
Same author

Psychological perspectives on male erectile dysfunction: a reappraisal.

Sexual medicine reviews·2025
Same author

The Hidradenitis Suppurativa Symptom and Impact Diary: Development and psychometric evaluation of a novel set of patient-reported outcomes for hidradenitis suppurativa.

The British journal of dermatology·2025
Same author

Psilocybin therapy for mood dysfunction in Parkinson's disease: an open-label pilot trial.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2025
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
Same journal

With great cost comes great responsibility: who will own the rising costs of bladder cancer care?

The Journal of urology·2026
See all related articles

The Erection Quality Scale effectively measures treatment benefits for erectile dysfunction, showing strong responsiveness and validity in clinical trials. This validated scale aids in assessing erectile function improvements.

Area of Science:

  • Urology
  • Clinical Pharmacology
  • Psychometrics

Background:

  • Erectile dysfunction (ED) significantly impacts quality of life.
  • Validated instruments are crucial for assessing treatment efficacy in ED clinical trials.
  • The Erection Quality Scale (EQS) is a patient-reported outcome measure for erection quality.

Purpose of the Study:

  • To evaluate the responsiveness and treatment sensitivity of the Erection Quality Scale (EQS).
  • To provide further psychometric validation for the EQS.
  • To assess the EQS's contribution to measuring erection quality in clinical trials.

Main Methods:

  • An 8-week, randomized, placebo-controlled trial of vardenafil for ED.
  • Administration of the EQS and other questionnaires at screening, baseline, and weeks 4 and 8.

Related Experiment Videos

  • Analysis of EQS responsiveness using treatment-induced changes and ANCOVA modeling, assessing internal consistency, validity, and minimum important difference.

    • Main Results:

    • The EQS demonstrated sufficient responsiveness to differentiate vardenafil's treatment benefits from placebo.
    • High internal consistency and reliability of the EQS items were observed across visits.
    • The EQS showed strong discriminant validity, correlating highly with the International Index of Erectile Function (IIEF) erectile function domain (0.88) and negligibly with unrelated measures.

    Conclusions:

    • The Erection Quality Scale is a responsive, internally consistent, and valid instrument for measuring erection quality.
    • The EQS offers a unique contribution to assessing erection quality beyond the IIEF.
    • Strong evidence supports the use of the EQS in clinical trials for erectile dysfunction treatment evaluation.